Peter M. Hecht
2018 - Ironwood Pharmaceuticals
In 2018, Peter M. Hecht earned a total compensation of $5.2M as Former Chief Executive Officer at Ironwood Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $1,192,500 |
|---|---|
| Option Awards | $3,842,268 |
| Salary | $100,000 |
| Other | $25,348 |
| Total | $5,160,116 |
Hecht received $3.8M in option awards, accounting for 74% of the total pay in 2018.
Hecht also received $1.2M in bonus, $100K in salary and $25.3K in other compensation.
Rankings
In 2018, Peter M. Hecht's compensation ranked 1,926th out of 14,244 executives tracked by ExecPay. In other words, Hecht earned more than 86.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,926 out of 14,244 | 87th |
Division Manufacturing | 696 out of 5,765 | 88th |
Major group Chemicals And Allied Products | 230 out of 2,128 | 89th |
Industry group Drugs | 182 out of 1,817 | 90th |
Industry Pharmaceutical Preparations | 140 out of 1,391 | 90th |
Source: SEC filing on April 26, 2019.
Hecht's colleagues
We found five more compensation records of executives who worked with Peter M. Hecht at Ironwood Pharmaceuticals in 2018.
2018
William Huyett
Ironwood Pharmaceuticals
Chief Operating Officer
2018
Mark Currie
Ironwood Pharmaceuticals
Chief Scientific Officer
2018
Thomas McCourt
Ironwood Pharmaceuticals
President
2018
Halley Gilbert
Ironwood Pharmaceuticals
Chief Administrative Officer
2018
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019